Advances in Hepatology
Objektkategorie:
Elektronische Ressource
Person/Institution:
Verlag:
IntechOpen
Ort:
[Erscheinungsort nicht ermittelbar]
Entstehungszeit:
2021
Sprache:
Englisch
Weitere Objektinformationen
Abstract:
This book discusses clinical advances in hepatology, with a focus on metabolic diseases and chronic hepatitis C. The development of direct-acting antiviral (DAA) agents for the treatment of hepatitis C virus (HCV) infection in 2010 has completely transformed the management of this disease. This transformative nature of DAA therapy underpins the goal of the World Health Organization (WHO) to eliminate HCV infection as a public health threat by 2030. The advantages of using these therapies include high efficacy (sustained virological response rate >95%) with minimal side effects, good tolerability, easy drug administration (once-daily oral dosing) and short duration of treatment (8-12 weeks). The commercialization of second-generation DAA agents due to their high effectiveness, few side-effects and pangenotypic action. This transformative nature of DAA therapy underpins the goal of the WHO to eliminate HCV infection as a public health threat by 2030
Objekttext:
English
Zugriff und Nutzungsmöglichkeiten
Administrative Angaben
Datensatz angelegt am:
2023-04-13
Zuletzt geändert am:
2022-03-10
In Portal übernommen am:
2023-04-13
Feedback
Unsere Datensätze befinden sich in stetiger Weiterentwicklung. Wenn Sie zusätzliche Informationen zu diesem Objekt oder einen Fehler entdeckt haben, dann schreiben Sie uns. Informationen zum Datenschutz